- Home
- LAKE vs CMPX Comparison
LAKE vs CMPX Comparison
Compare LAKE & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- CMPX
- Stock Information
- Founded
- LAKE 1982
- CMPX 2014
- Country
- LAKE United States
- CMPX United States
- Employees
- LAKE N/A
- CMPX N/A
- Industry
- LAKE Industrial Specialties
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- LAKE Health Care
- CMPX Health Care
- Exchange
- LAKE Nasdaq
- CMPX Nasdaq
- Market Cap
- LAKE 234.8M
- CMPX 214.6M
- IPO Year
- LAKE 1986
- CMPX N/A
- Fundamental
- Price
- LAKE $24.72
- CMPX $2.92
- Analyst Decision
- LAKE Strong Buy
- CMPX Strong Buy
- Analyst Count
- LAKE 2
- CMPX 6
- Target Price
- LAKE $27.50
- CMPX $12.50
- AVG Volume (30 Days)
- LAKE 90.7K
- CMPX 1.4M
- Earning Date
- LAKE 04-09-2025
- CMPX 03-20-2025
- Dividend Yield
- LAKE 0.49%
- CMPX N/A
- EPS Growth
- LAKE N/A
- CMPX N/A
- EPS
- LAKE N/A
- CMPX N/A
- Revenue
- LAKE $151,822,000.00
- CMPX $850,000.00
- Revenue This Year
- LAKE $37.18
- CMPX N/A
- Revenue Next Year
- LAKE $22.27
- CMPX $613.39
- P/E Ratio
- LAKE N/A
- CMPX N/A
- Revenue Growth
- LAKE 23.99
- CMPX N/A
- 52 Week Low
- LAKE $15.10
- CMPX $0.77
- 52 Week High
- LAKE $27.28
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- LAKE 54.44
- CMPX 48.30
- Support Level
- LAKE $23.86
- CMPX $3.14
- Resistance Level
- LAKE $25.53
- CMPX $3.85
- Average True Range (ATR)
- LAKE 0.97
- CMPX 0.33
- MACD
- LAKE 0.13
- CMPX -0.11
- Stochastic Oscillator
- LAKE 75.38
- CMPX 5.68
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.